Seeking Alpha on MSN55m
Hims & Hers Health falls as FDA issues unfavorable compounded GLP-1 decisionHims & Hers Health (NYSE:HIMS) is down 7% in early morning trading after the U.S. FDA determined that there is no shortage of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback